ECM
AGIO icon

ETrade Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

ETrade Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$450K Buy
12,866
+836
+7% +$36.6K 0.01% 595
2020
Q2 		$643K Buy
+12,030
New +$557K 0.01% 485

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ETrade Capital Management's AGIO Position: Q3 2020 in Review

ETrade Capital Management increased its Agios Pharmaceuticals (AGIO) stake by 6.9% in Q3 2020, buying an estimated $36.6K and bringing the position to 12,866 shares worth $450K. The position accounts for 0.01% of the portfolio, ranked #595.

ETrade Capital Management first reported a position in AGIO in Q2 2020 and has held it in 2 quarters since. The position peaked at $643K in Q2 2020. 215 funds tracked by Wall St. Rank hold AGIO as of Q3 2020.

  • ETrade Capital Management held 12,866 shares of Agios Pharmaceuticals worth $450K as of Q3 2020.
  • ETrade Capital Management bought 836 Agios Pharmaceuticals shares in Q3 2020, an estimated $36.6K.
  • Agios Pharmaceuticals made up 0.01% of ETrade Capital Management's portfolio in Q3 2020, its #595 holding.
  • ETrade Capital Management first reported a position in Agios Pharmaceuticals in Q2 2020 and has held it in 2 quarters since.
  • ETrade Capital Management's Agios Pharmaceuticals position peaked at $643K in Q2 2020.
  • 215 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.